Drug intelligence / Profile preview

NanoFUSE DBM

Development stage
Unknown
Lead developer
NanoFUSE Biologics
Modality
Nanoparticles → Drug Delivery Systems
Administration
Implant
01

Overview

NanoFUSE DBM is an FDA‑cleared, malleable, putty‑like composite bone void filler that combines human demineralized bone matrix (DBM) with synthetic 45S5 calcium phosphor‑silicate bioactive glass particles to provide both osteoinductive and osteoconductive (osteopromotive) properties for bone regeneration in orthopedic applications.[1][2][9] The DBM component supplies endogenous bone growth factors and a collagenous scaffold that induce and support osteoblast differentiation, while the bioactive glass rapidly releases calcium, phosphate, sodium, and silica ions to form a hydroxyapatite layer, stimulate osteogenic cell activity, enhance angiogenesis, and provide structural graft containment.[1][3][8] Indicated for filling bony voids or gaps in the extremities and pelvis and, when combined with autograft, as a bone graft extender in posterolateral spinal fusion, NanoFUSE DBM is progressively resorbed and remodeled into host bone and has demonstrated biocompatibility, osteoconductivity, and ectopic osteoinductivity in preclinical studies and a history of safe clinical use.[1][2][5]

Brand names
NanoFUSE DBMNanoFUSE
Other names
NanoFUSE Bioactive MatrixOrigen DBM with Bioactive Glass

Beyond the preview

Go deeper on NanoFUSE DBM.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NanoFUSE DBM.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call